Please login to the form below

Not currently logged in
Email:
Password:

binge eating disorder

This page shows the latest binge eating disorder news and features for those working in and with pharma, biotech and healthcare.

Shire pitching at adult ADHD product launch in 2017

Shire pitching at adult ADHD product launch in 2017

The FDA has agreed a regulatory route for Shire's attention deficit hyperactivity disorder (ADHD) product for adults, potentially opening up a lucrative new market for the company's franchis e. ... Breaking into the adult ADHD - as well as a sideways

Latest news

  • Monica Seles to front Shire’s binge eating disorder campaign Monica Seles to front Shire’s binge eating disorder campaign

    Seles recently admitted to experiencing binge eating disorder when she was a professional tennis player in the 1990s. ... There is a misconception that adults with binge eating disorder fit a certain profile,” said Seles.

  • Shire gets FDA nod for first binge-eating treatment Shire gets FDA nod for first binge-eating treatment

    Vyvanse already available as ADHD treatment. Shire's big-selling Vyvanse brand has become the first drug approved in the US to help people with binge-eating disorder. ... Binge eating disorder is not just about eating a lot; it is that, plus being out of

  • Shire to file Vyvanse for binge-eating in Q3 Shire to file Vyvanse for binge-eating in Q3

    Shire is planning a marketing application in binge-eating in the third quarter, which, if approved, would be the first FDA-backed drug for the condition, potentially adding tens of millions ... Shire wants to achieve with binge-eating disorder what it

  • Shire's ADHD drug fails in depression trial Shire's ADHD drug fails in depression trial

    Company drops Vyvanse for use in major depressive disorder. Shire's hopes to expand the uses of its big-selling behavioural medicine Vyvanse were dashed after the drug disappointed in a ... of adults with binge eating disorder.

  • Shire weathers generic Adderall XR challenge Shire weathers generic Adderall XR challenge

    attention deficit-hyperactivity disorder (ADHD) drug Adderall XR (amphetamine and dextroamphetamine). ... Russell highlighted developments, such as potential new indications for Vyvanse, including major depressive disorder, binge eating disorder and

More from news
Approximately 1 fully matching, plus 5 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

4 ways to recruit Alzheimer’s disease patients for your clinical trial
What key things do you need to remember to reach patients living with Alzheimer’s disease?...
competitive intelligence
Integrating competitive intelligence into business development, licensing and M&A strategy
The advantages of partnering with a competitive intelligence or knowledge management team...
reaching HCPs during pandemic
Reaching patients and HCPs during the pandemic
COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...

Infographics